Quantcast

Latest Peripheral vascular disease Stories

2011-07-28 07:25:00

LAKEWOOD, Colo., July 28, 2011 /PRNewswire-USNewswire/ -- The Vascular Disease Foundation (VDF) is pleased to announce that Thomas R.

2011-07-25 07:36:00

MINNEAPOLIS, July 25, 2011 /PRNewswire/ -- Lutonix today announced the first patient enrolled in the LEVANT 2 clinical trial, a global, multicenter, randomized trial evaluating the safety and efficacy of the Moxy(TM) Drug Coated Balloon compared to a standard angioplasty balloon for the treatment of peripheral arterial disease (PAD).

2011-07-20 12:27:51

As the population ages and obesity and diabetes increase, more people suffer from noncardiac vascular diseases.

2011-06-28 09:56:00

MINNEAPOLIS, June 28, 2011 /PRNewswire/ -- Lutonix today announced receiving approval from the US Food and Drug Administration to begin enrollment in its LEVANT 2 IDE clinical trial for the treatment of peripheral arterial disease (PAD), along with receipt of CE Mark for its drug-coated balloon and ISO certification.

2011-06-23 06:26:32

Millions of adults with peripheral artery disease (PAD) are not receiving the medications needed to reduce their risk of heart attack, stroke and death, according to this study.

2011-06-21 02:01:37

Millions of adults with peripheral artery disease are not receiving the medications needed to reduce their risk of heart attack, stroke and death.

2011-06-20 19:47:07

Outcomes of bypass surgery to repair blocked arteries in the legs tend to be better in the roughly one-in-five people who have inherited a specific genetic variation from both parents.

2011-06-20 07:30:00

NATICK, Mass., June 20, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the global launch of its Mustang(TM) PTA Balloon Catheter, a highly deliverable 0.035 inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures.

2011-06-13 08:59:00

MONTREAL, June 13, 2011 /PRNewswire/ -- Researchers today announced the results of a study that show echocardiography can improve the success rate of gene therapy and increase growth, function and sustainability of regenerated vessels.

2011-05-04 15:07:00

SAN DIEGO, May 4, 2011 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), the leading developer and manufacturer of precision guided therapy tools designed to enhance the treatment of coronary and peripheral vascular disease, today announced the signing of a supply agreement with ev3, a Covidien company, under which Volcano will supply its proprietary Intravascular Ultrasound (IVUS) technology for use in ev3's Plaque Excision Systems.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.